510(k) · Cleared
Recalled · 2010Modification to: Nanocross 0.14 Otw Pta Dilatation Catheter, Models AB14W020210090, AB14W020210150
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Ev3, Inc. · DQY Catheter, Percutaneous
Cleared on May 1, 2009 as substantially equivalent to K082854 (Ev3, Inc., 2008) after a 32-day review. Its family tree reaches back 1 generation to 2008. 25 later devices descend from it. It has been recalled once.
- Decided
- May 1, 2009
- Review
- 32 days
- Class
- Class II
- Product code
- DQY
- Recalls
- 1
- Predicates
- 1
Its longest line of descent runs back 1 generation to K082854 (2008). 25 later devices descend from it, 9 citing it directly.
- Root · 1 generation backK082854 Nanocorss .014 Otw Pta Dilatation CatheterEv3, Inc. · 2008 · Recalled
- This deviceK090849 Modification to: Nanocross 0.14 Otw Pta Dilatation Catheter, Models…Ev3, Inc. · 2009
- Descendant · cites it directly · 14 of its ownK093286 Powercross .018 Otw Pta Dilation CatheterEv3, Inc. · 2009 · Recalled
- Descendant · cites it directly · 8 of its ownK123544 Rapidcross Pta Rapid Exchange, Balloon Dilatation CatheterEv3, Inc. · 2013
- Descendant · cites it directly · 8 of its ownK101062 Glider Pta Balloon CatheterTrireme Medical, Inc. · 2010
- Descendant · 2 generations on · 7 of its ownK130911 Rapidcross Pta Rapid Exchange Balloon Dilatation CatheterEv3, Inc. · 2013
- Descendant · cites it directly · 6 of its ownK132777 Nanocross Elite .14 Over-the-Wire Pta, Balloon Dilation CatheterEv3, Inc. · 2013
Showing 5 of 25 descendants. See all descendants
Descendants cleared per year
Most influential descendants
Showing 5 of 25 · See all- K093286Powercross .018 Otw Pta Dilation CatheterEv3, Inc. · 2009 · cites it directly14descendants
- K123544Rapidcross Pta Rapid Exchange, Balloon Dilatation CatheterEv3, Inc. · 2013 · cites it directly8descendants
- K101062Glider Pta Balloon CatheterTrireme Medical, Inc. · 2010 · cites it directly8descendants
- K130911Rapidcross Pta Rapid Exchange Balloon Dilatation CatheterEv3, Inc. · 2013 · 2 generations on7descendants
- K132777Nanocross Elite .14 Over-the-Wire Pta, Balloon Dilation CatheterEv3, Inc. · 2013 · cites it directly6descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −1 | K082854 | Nanocorss .014 Otw Pta Dilatation Catheter | Ev3, Inc. | 2008 | 1 |
| 0 (this device) | K090849 | Modification to: Nanocross 0.14 Otw Pta Dilatation Catheter, Models… | Ev3, Inc. | 2009 | — |
| +1 | K093286 | Powercross .018 Otw Pta Dilation Catheter | Ev3, Inc. | 2009 | 2 |
| +1 | K123544 | Rapidcross Pta Rapid Exchange, Balloon Dilatation Catheter | Ev3, Inc. | 2013 | — |
| +1 | K101062 | Glider Pta Balloon Catheter | Trireme Medical, Inc. | 2010 | — |
| +2 | K130911 | Rapidcross Pta Rapid Exchange Balloon Dilatation Catheter | Ev3, Inc. | 2013 | — |
| +1 | K132777 | Nanocross Elite .14 Over-the-Wire Pta, Balloon Dilation Catheter | Ev3, Inc. | 2013 | — |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2009 | 1 | 0 |
| 2010 | 2 | 0 |
| 2011 | 3 | 0 |
| 2012 | 3 | 0 |
| 2013 | 4 | 0 |
| 2014 | 1 | 0 |
| 2015 | 2 | 0 |
| 2016 | 4 | 0 |
| 2020 | 1 | 0 |
| 2021 | 1 | 0 |
| 2024 | 1 | 0 |
| 2025 | 1 | 0 |
| 2026 | 1 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in DQY? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new DQY device
- #1 K234115 APRO 55 Catheterscore 17.5 · 6 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (1)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K082854 | Nanocorss .014 Otw Pta Dilatation CatheterSummary page 1…ous Classification Panel Cardiovascular Predicate Device NanoCross .014" OTw PTA Dilatation Catheter (K082854) Intended use =h =aoMs774715T o… | 2008 |
What descends from it? (25)
See all 259 later devices cite it directly; ranked here by how many devices descend from each in turn.
| Number | Device | Decided | Descendants |
|---|---|---|---|
| K093286 | Powercross .018 Otw Pta Dilation Catheter | 2009 | 14 |
| K123544 | Rapidcross Pta Rapid Exchange, Balloon Dilatation Catheter | 2013 | 8 |
| K101062 | Glider Pta Balloon Catheter | 2010 | 8 |
| K132777 | Nanocross Elite .14 Over-the-Wire Pta, Balloon Dilation Catheter | 2013 | 6 |
| K103534 | Gliderxtreme Pta Balloon Catheter (CB) (Over the Wire) 0.014 / 0.018 Guide Wire | 2011 | 6 |
| K111738 | Chocolate Pta Balloon Catheter (Over the Wire) Guide Wire (0.014 and 0.018) | 2011 | 5 |
| K120677 | Chocolate Pta Ballon Catheter (Over the Wire) Guide Wire (0.014) | 2012 | 4 |
| K094019 | Glider Pta Balloon Catheter | 2010 | 4 |
| K121402 | Chocolate Pta Balloon Catheter (Over the Wire) 0.014 Guide Wire Chocolate Pta Balloon… | 2012 | 3 |
Has anything in its family been recalled? (0 Class I)
Recalls of this device
| Date | Class | Recall | Root cause | Reason |
|---|---|---|---|---|
| Nov 12, 2010 | Not classified | Z-0789-2011 | Process control | ev3 has determined that specific lots of the NanoCross .014 OTW PTA Dilatation catheters may crack or break during use. Cracking or breaking of the catheter shaft can result in the inability to inflate or deflate the balloon, and can… |
No ancestor or descendant has a Class I recall.
What does this lineage say?
How does its category compare?
All DQY devicesDQY Catheter, Percutaneous: FDA decisions, review times, recalls and adverse event reports over 20 years. 2009, this device’s year, is highlighted.
FDA decisions per year · DQY
21in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · DQY
115in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · DQY
1in 2025
Class I (10 since 2007) Class II/III not classified
Adverse event reports per year · DQY
3,056in 2025
MAUDE reports naming product code DQY, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 16 | 85 | 6 | 313 |
| 2008 | 31 | 66 | 12 | 496 |
| 2009 | 37 | 73 | 17 | 819 |
| 2010 | 22 | 74 | 32 | 1,293 |
| 2011 | 36 | 71 | 6 | 1,211 |
| 2012 | 30 | 87 | 2 | 1,191 |
| 2013 | 32 | 92 | 36 (1) | 1,352 |
| 2014 | 19 | 127 | 3 | 1,497 |
| 2015 | 27 | 118 | 3 | 2,337 |
| 2016 | 22 | 117 | 22 (7) | 2,252 |
| 2017 | 26 | 113 | 8 | 2,489 |
| 2018 | 25 | 106 | 2 | 2,855 |
| 2019 | 30 | 111 | 1 | 2,902 |
| 2020 | 20 | 120 | 2 | 2,889 |
| 2021 | 18 | 81 | 2 | 3,006 |
| 2022 | 18 | 74 | 0 | 2,643 |
| 2023 | 18 | 114 | 17 | 3,049 |
| 2024 | 16 | 87 | 1 | 3,190 |
| 2025 | 21 | 115 | 1 (1) | 3,056 |
| 2026 | 11 | 30 | 2 (1) | — |
What is it indicated for?
The NanoCross 0.014" OTW PTA Dilatation Catheter is intended to dilate stenoses in the
iliac, femoral, ilio-femoral,.popliteal, infra-popliteal, and renal arteries; and for the
treatment of obstructive lesions of native or synthetic arteriovenous dialysis fistulae.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K090849 · printed Nov 6, 2026
Cite this page
510(k) Report. “K090849: Modification to: Nanocross 0.14 Otw Pta Dilatation Catheter, Models AB14W020210090, AB14W020210150.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K090849
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026